Xiidra Approved; Pending Effective Date

Posted in Latest News on September 14, 2016.

At the August 19, 2016 Board of Optometry meeting, the board voted and approved the use of Xiidra (Lifitegrast ophthalmic solution 5%) for dry eyes. The formulary rule is in the process of being changed to include Lifitegrast ophthalmic solution 5%.

Until the new rule becomes effective, Florida Optometrists are not allowed to prescribe the medication. The board will place a notification on the website advising when the addition to the rule has become effective.



More Latest News

Important Information Regarding Rhopressa
June 26, 2018

Click here to find out more about Rule 64B13-18.002 formulary of Topical Ocular Pharmaceutical Agents, Rhopressa (netarsudil ophthalmic solution) 0.02%.) Continue reading


Third Quarterly Performance Report Released for the 2017-2018 Fiscal Year
June 8, 2018

The Quarterly Performance Report for the third quarter of the 2017-2018 fiscal year is now available online. Continue reading